Home › Viral Infections › Virginia › Richmond
Viral Infections clinical trials in Richmond, VA
3 studies for Viral Infections are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
RecruitingPhase 2Healthy volunteers welcome
- Clinical Research Partners, Richmond
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RecruitingPhase 2
- Clinical Research Partners LLC, Richmond
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
RecruitingPhase 4Healthy volunteers welcome
- Richard Bennett - Clinical Research Partners, Richmond
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Washington, DC11 studies
- Houston, TX7 studies
- Hialeah, FL6 studies
- Boston, MA6 studies
- Baltimore, MD5 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Cincinnati, OH4 studies
- Miami, FL4 studies
- New York City, NY4 studies
- Columbus, OH4 studies
- Salt Lake City, UT3 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.